抗体效价(log2)
" L/ S, Q1 @1 u& V; d0 T% n | 攻毒数
+ l) i9 c; n$ Q9 v3 a9 G | 死亡数 0 ~& ^; g# E- d+ O* F
| 存活数
' X3 J! d9 x9 |; ^ | 保护率%
' Z K$ a8 s+ g5 t1 r! C5 a |
0
9 S' P3 l- l$ \1 H* B. B1 } | 6. p" R3 T( }8 u" |" s( d3 Z
| 6) h8 h3 t3 m+ k1 X) _: t
| 0# h3 K/ l. ]+ W, Y
| 0( [% i! @" r1 V# O( o6 t
|
1
# Q) l) w6 X9 ~1 U7 H8 T, z | 6
8 Q. i( T) A0 H3 u | 6
2 u, U! A8 i* T8 {( e, t. g* y | 0
" ]5 x$ f4 @' L% ?7 p& g2 f | 0( d% ~' H/ x' ?2 `: P
|
2
* ~! ^- h/ K$ y' U9 E ` | 6
! a6 E9 h1 E9 I! @ | 3
) p( e6 m1 r: w$ i | 3
& j7 h( P1 D4 X6 p) p | 50 ! K$ N+ k4 q: @4 k3 i% l3 `0 `
|
3
. r2 k5 m( K0 N& E+ ]6 b3 L | 6
& c1 ?$ P# t' W8 ?3 N1 w3 t | 0 6 C; A8 N8 K8 d/ c+ T4 A) E
| 6
7 G0 [0 g2 M) `1 e1 Q* Z5 T | 100 * W% O% V1 ^& u7 O: r
|
4 + h3 R; s/ U) F1 R- N
| 6
5 J* v; _; w7 K% x% y | 0
4 t. u# I8 T: D6 D | 6
6 |4 Y- x# H- d+ m" V! v) D | 100
7 w# F+ o& Y4 g |
$ |9 c! }8 D, p! |5 m8 o7 n* r1 P
日龄; P4 P, @& U6 i3 _' Y1 `
| ' n( v7 v- E. `% A
免疫后
( j& O; j! q" F; p: r8 ^3 Y |
1周 $ `) Z5 E; a- ~/ Y0 ^9 E. A Z- d
| 2周
4 P: t3 `# H: }9 F! E2 K | 3周 % X l( \/ v- l7 {* \
| 4周
e! t: {0 ]+ R9 j& r! D7 h | 5周
. o' B9 l' T l! Z* n | 6周 - s i( U; i7 e3 V
| 7周
- M! P L4 P& n4 P. S5 _) u. G% u* d | 8周
# K4 \6 E$ {) U4 ~9 r* w |
30' _1 }1 g7 i6 u5 e
| 1.67±0.58c/ c, p0 R7 m( `& Z. Y! `' g- L( c- f
| 2.75±0.96bc% |- Z4 c2 ]5 l+ @7 F4 ?7 j
| 1.75±0.96b" Y& g! i: x6 X6 R
| 1.00±0.00d
* I3 O* ~! v2 M! l' x | 0.25±0.50c
6 I7 r7 L& y, A | 0.13±0.25c
( v7 n, \' b# U2 O0 ^, ] | 0
0 E) v9 W- i- v7 j& e# [ | 0- }1 s8 h- _) k
|
350 s5 l' F; C# k& O( V: Q) x5 s
| 3.25±0.50ab1 ~1 _5 U) J7 e' X
| 3.00±0.82bc
" `) ^+ X) i; v% Z7 ~# A$ m | 2.38±0.49b* t: }: k* c$ x& b9 b& I
| 2.00±0.00c; f V2 t1 ?& _$ ?3 M) g: D
| 1.00±0.00c) T' b& U* V9 b2 B( g
| 0.75±0.50c+ Z% h5 {/ c- l
| 0& z1 ?! x, L7 V f1 r/ {
| 0
% ]) L2 P$ r; `0 C6 A/ U) z* D |
402 [" P# k; a8 b( c K: }% Q
| 3.00±0.82ab
# T D n/ |* I6 |9 |: e, C+ P X2 n; x | 5.75±1.71a
+ n+ n( _8 e9 ?2 |" E | 5.00±1.83a
$ I2 e% |8 I& O# l2 h. p8 g# | | 3.25±1.50b
, t1 A" e7 ~2 e | 3.00±0.82b
& E2 p& x# K& f | 2.13±0.50b: [" e7 i: b& \. p8 u! L
| 1.83±0.58bc6 \$ [0 W) p' K9 l% ~/ L
| 1.03±0.63bc, y6 U2 ]: \' y1 R8 n& L
|
457 R- g$ p H8 R+ s. X% o
| 3.25±1.26ab( c( Q! X5 d9 F" x$ K
| 4.25±0.96ab: P4 h( U. l/ D# D4 s. S
| 5.50±1.29a2 \+ A( y5 _1 }$ R, W
| 3.75±0.96b
# V) ^& o8 \4 E% w$ a7 i | 3.25±1.26b( w. \7 w/ m6 \
| 2.38±1.80b
, j8 n+ z3 J7 e+ d4 I. b) {: l9 V | 2.00±1.41bc
' ~' W0 r0 i1 i | 1.13±0.63bc/ x6 d% ^% I& C3 c- @
|
50
1 X) j F6 {0 i. Z" M$ d | 2.25±0.50bc
& B. ^; L8 A0 v; R3 M | 4.25±0.96ab
6 } b8 |3 N9 Y5 }7 h9 s | 4.50±2.08a8 [) q3 {1 X; b6 O/ R; y( u+ D
| 5.75±0.50a0 U, W$ J! O7 d D3 x# D
| 6.00±0.00a
' x2 `5 X+ r; Z" f& c | 5.00±0.00a- z+ c0 @: z3 y' C
| 3.5±0.58ab
# [; P5 \ n! B; p0 ^0 r N3 D | 1.50±0.58b7 j0 b, Y6 O: _1 |0 w S
|
55( k" r; ^$ j7 l& c3 z( F+ H- E1 I( S
| 3.50±0.58a8 ?" M, u* e7 C; H' S: [
| 4.75±0.50a
$ P- i9 K) M, e0 n, Y( f0 B; | | 6.00±0.82b
2 M A4 M9 E( W/ h3 I9 x1 f4 ] s | 5.75±1.50a
' b7 B' B J5 i3 G | 5.25±0.96a9 E& W; l' ^5 w/ y$ D# L7 V5 d
| 4.25±0.50a- j# C0 _* |0 e* P2 }* c
| 3.25±0.96b
% N- v) c- F. v0 Q! R1 p3 \ | 2.75±1.26ab5 `$ M4 t3 b+ J; _& E0 f6 w
|
603 g# N( {+ g/ p5 [" A' S, i
| 3.50±0.58a
7 A# B4 r( z6 c: Z | 5.00±0.82a, g P0 d; [7 r7 D- d2 R
| 6.25±0.50a
" l$ a }! A4 K" x. W1 p | 5.75±0.96a
4 u) \* |$ ?6 u | 5.00±0.82a
, f1 T, p) }3 {3 P9 h | 4.13±0.85a
& T$ M3 |1 w3 L: G+ x* e | 3.25±0.96b
" P9 e' p4 Q5 K7 \0 m | 2.25±0.96b3 Z+ b3 p( i2 _8 A1 m
|